IBANDRONATE SODIUM
NDC 69452-378, IBANDRONATE SODIUM, tablet, from Bionpharma Inc..
- Product NDC
- 69452-378
- Status
- Listed
- Labeler
- Bionpharma Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078998
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69452-378 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBANDRONATE SODIUM150 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69452-378-74 | 69452037874 | 1 BLISTER PACK in 1 CARTON (69452-378-74) / 3 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6ca94cce-a2bb-421f-bd8f-6b14bc2bd985NADAC price for package 69452037874
GET /v1/drugs/nadac/69452037874
Use it
Look up 69452-378 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69452-378 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69452-378. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.